Replimune Group, Inc. (REPL)
8.87
-0.10
(-1.11%)
USD |
NASDAQ |
Jun 09, 14:10
Replimune Group Total Assets (Quarterly) : 333.59M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 2.254B |
| Oncolytics Biotech, Inc. | 8.161M |
| Rocket Pharmaceuticals, Inc. | 285.41M |
| Cogent Biosciences, Inc. | 903.01M |
| Lantern Pharma, Inc. | 7.223M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.05M |
| Shareholders Equity (Quarterly) | 210.54M |
| Debt to Equity Ratio | 0.3626 |
| Current Ratio | 5.597 |
| Net Debt Paydown Yield | -0.01% |